Realtimekurse aktiv
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 2,660 | 2,710 | 07:00 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | |
|---|---|---|---|---|
| Fr | GeoVax Labs, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | |
| Do | GeoVax Labs, Inc. - 8-K, Current Report | 1 | SEC Filings | |
| 02.05. | GeoVax reports Q1 results | 4 | Seeking Alpha | |
| 02.05. | Geovax highlights progress on mpox vaccine and COVID-19 trial advancements | 1 | Seeking Alpha | |
| 01.05. | GeoVax Labs, Inc. - 8-K, Current Report | - | SEC Filings | |
| 01.05. | GeoVax Labs, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | |
| 28.04. | Geovax Labs is a buy, Roth says | 7 | Cantech Letter | |
| GEOVAX LABS Aktie jetzt für 0€ handeln | ||||
| 14.04. | GeoVax ordered to halt work on COVID-19 vaccine project by ATI | 3 | Investing.com | |
| 14.04. | GeoVax muss Arbeit an COVID-19-Impfstoffprojekt auf Anweisung von ATI einstellen | 8 | Investing.com Deutsch | |
| 14.04. | GeoVax Labs, Inc. - 8-K, Current Report | 1 | SEC Filings | |
| 27.03. | GeoVax Labs, Inc. - 10-K, Annual Report | 2 | SEC Filings | |
| 26.03. | What's Next: Geovax Labs' Earnings Preview | 2 | Benzinga.com | |
| 25.03. | GeoVax Labs, Inc. - 8-K, Current Report | 2 | SEC Filings | |
| 22.01. | GeoVax Labs, Inc. - 8-K, Current Report | 1 | SEC Filings | |
| 18.12.24 | GeoVax Labs, Inc. - 8-K, Current Report | 2 | SEC Filings | |
| 18.12.24 | Nitches, inc: Nitches Inc. Updates Shareholders on Amazon Integration, GovX Integration, and 2025 Growth Strategy for InTheZone Labs | 276 | ACCESS Newswire | |
| 09.12.24 | GeoVax, Inc.: GeoVax Receives Notice of Allowance For Cancer Vaccine Patent | 287 | GlobeNewswire (Europe) | |
| 20.08.24 | GeoVax, Inc.: GeoVax to Raise Approximately $8.5 Million of Gross Proceeds in Offering Priced Above-the-Market | 429 | GlobeNewswire (Europe) | |
| 31.07.24 | GeoVax, Inc.: Update: GeoVax Announces Phase 2 Plans for Gedeptin Cancer Therapy Following Clinical Advisory Committee Review | 253 | GlobeNewswire (Europe) | |
| 31.07.24 | GeoVax, Inc.: GeoVax Announces Phase 2 Plans for Gedeptin Cancer Therapy Following Clinical Advisory Committee Review | 220 | GlobeNewswire (Europe) |
1 2 Weiter >>
21 Nachrichten in den letzten 12 Monaten
GEOVAX LABS INC gehört der Branche Biotechnologie an. Die relative Kursveränderung beträgt aktuell -100,00 % bei einem Aktienkurs von 2,685 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GEOVAX LABS INC finden Sie auf Wallstreet Online.